Article Text
Correction
Correction: Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
Statistics from Altmetric.com
Hunt B, Malkin SJP, Moes RGJ, et al. Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands. BMJ Open Diabetes Research and Care 2019;7:e000705. doi: 10.1136/bmjdrc-2019-000705.
This article was previously published with an error.
Details of author Bruce Wolffenbuttel have changed. The correct name is Bruce H R Wolffenbuttel and the correct affiliation is University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Linked Articles
- Emerging Technologies, Pharmacology and Therapeutics